Cerus Corporation (NASDAQ:CERS) tinted gains of +6.15% (+0.43 points) to US$7.42. The volume of 1.97 Million shares climbed down over an trading activity of 974.42 Million shares. EPS ratio determined by looking at last 12 month figures is -0.5. Over the same time span, the stock marked US$7.31 as its best level and the lowest price reached was US$2.1. The corporation has a market cap of US$954.88 Million.
Cerus Corporation (NASDAQ:CERS)’s earnings per share has been growing at a -13.9 percent rate over the past 5 year when average revenue increase was noted as 6.9 percent. The return on equity ratio or ROE stands at -111.2 percent while most common profitability ratio return on investment (ROI) was -89.4 percent. The company’s institutional ownership is monitored at 64.2 percent. The company’s net profit margin has achieved the current level of -93.3 percent and possesses 56.3 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 1 think it is Hold. Recently, analysts have updated the overall rating to 1.8. 2 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
Geron Corporation (NASDAQ:GERN) is worth US$624.23 Million and has recently risen 6.13% to US$3.81. The latest exchange of 3.73 Million shares is below its average trading activity of 4.99 Million shares. The day began at US$3.58 but the price moved to US$3.53 at one point during the trading and finally capitulating to a session high of US$3.83. The stock tapped a 52-week high of US$6.68 while the mean 12-month price target for the shares is US$5.75.
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 6.05, and a price to sales ratio of 780.29. For the past 5 years, the company’s revenue has grown -17%, while the company’s earnings per share has grown 20.2%. With an institutional ownership near 35.1%, it carries an earnings per share ratio of -0.18.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 0 brokerage firms polled by Factset Research. At present, 1 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 1 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.5.